0001203311-21-000036.txt : 20210518
0001203311-21-000036.hdr.sgml : 20210518
20210518193519
ACCESSION NUMBER: 0001203311-21-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210514
FILED AS OF DATE: 20210518
DATE AS OF CHANGE: 20210518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simonian Nancy A
CENTRAL INDEX KEY: 0001359574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 21937889
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-05-14
0
0001060736
Seagen Inc.
SGEN
0001359574
Simonian Nancy A
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
Common Stock
2021-05-14
4
A
0
1402
0.0
A
27500
D
Non-Qualified Stock Option (right to buy)
147.5
2021-05-14
4
A
0
3462
0.0
A
2022-05-14
2031-05-14
Common Stock
3462
3462
D
These restricted stock units will be settled in common stock upon vesting.
These restricted stock units shall vest in full on May 14, 2022.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Elizabeth Bekiroglu For: Nancy Simonian
2021-05-18